Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Arta M. Monjazeb(University of California Davis Medical Center), Karen Kelly(Cancer Research Center), Shuai Chen(Hong Kong Polytechnic University), Alexander A. Merleev(UC Davis Health), Logan V. Vick(UC Davis Health), Kurt A. Schalper(Yale University), Megan E. Daly(University of California Davis Medical Center), Leslie Garcia(UC Davis Health), William J. Murphy(University of California Davis Medical Center), Heather M. McGee(City of Hope), Laurel Beckett(Brigham and Women's Hospital), Stephen L. Shiao(Cedars-Sinai Medical Center), Robert J. Canter(Virginia Tech), Alexander D. Borowsky(University of California, San Francisco), Alina I. Marusina(UC Davis Health), Tianhong Li(VA Northern California Health Care System), Jonathan W. Riess(University of California Davis Medical Center), Guillaume Luxardi(UC Davis Health), Amin Mirhadi(Cedars-Sinai Medical Center), Frances Lara, D.V. Eastham(David Grant USAF Medical Center), Leigh Anne Morris(UC Davis Health), Emanual Maverakis(University of California, Davis)
Cited by 21
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
|Journal of Clinical Oncology|2021|1.1k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|805
siRNA-directed inhibition of HIV-1 infection
|Nature Medicine|2002|777